Care

A Montreal study assigned patient navigators to 10 men released from prison with hepatitis C; Navigators’ knowledge and attitudes were more important to participants than lived experience. More

MSF: "We learned that any serious effort to combat this disease has to tackle not just the medical aspects, but also the social conditions that allow it to spread." More

Telehealth can reduce barriers to HCV care for people who use drugs, addressing stigma and geographical challenges; Focus group participants in Greece recognized telehealth benefits but had concerns about diagnostic accuracy without physical exams. More

A study in rural Oregon finds 66% of hard-to-reach patients cleared the virus with peer-assisted telehealth. More

Findings from a project which established hepatitis C point-of-care testing and linkage to care at a homelessness service in Adelaide, Australia, 2021–2022. More

Introducing a hepatitis C outreach and treatment program in Australian community pharmacies, particularly those offering opioid agonist therapy, could significantly increase testing, diagnosis, and cure of those living with the virus. More

In 2023, Egypt became the first country to fulfill the World Health Organization’s set programmatic criteria of reduction of hepatitis C incidence and mortalities to levels close to elimination of disease. More

A study developed an agent-based model to characterize the HCV epidemic in Canada, a resource-rich country with ongoing immigration from HCV-endemic regions, relying exclusively on risk-based screening for case identification. More

A case study, published in MMVR, explored Georgia’s efforts and progress toward hepatitis B and hepatitis C elimination. More

A study, published in Drugs - Real World Outcomes, quantified the incidence of cancer in patients treated with HCV therapies in Catalonia, Spain and their matched controls. More